14-day Premium Trial Subscription Sign Up For FreeGet Free

BioLineRx Ltd. Stock Forecast NASDAQ:BLRX

Price Target and Analyst Ratings

Most Recent Rating

Maxim Group is very positive about BLRX and gave it a "Buy" rating on May 04, 2021. The price target was changed from $5.00 to $10.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-04 Buy Target Raised by Maxim Group $4.88 $5.00 → $10.00
2021-03-01 Buy Target Lowered by HC Wainwright $3.16 $22.00 → $19.00
2021-02-23 Buy Reiterated by HC Wainwright $3.33 $22.00 → $19.00
2021-02-23 Buy Reiterated by HC Wainwright $3.33
2020-12-16 Buy Target Raised by HC Wainwright $2.86 $18.00 → $22.00
2020-08-07 Buy Reiterated by Maxim Group $2.15
2020-07-20 Buy Reiterated by HC Wainwright $1.95

BLRX Stock Trend

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.56 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -8.33% during the next 3 months and, with a 90% probability hold a price between $2.34 and $2.85 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-22 $2.55 $2.83 $3.10
2021-09-23 $2.55 $2.82 $3.10
2021-09-24 $2.54 $2.82 $3.09
2021-09-27 $2.54 $2.81 $3.09
2021-09-28 $2.53 $2.81 $3.09
2021-09-29 $2.53 $2.81 $3.08
2021-09-30 $2.52 $2.80 $3.08
2021-10-01 $2.52 $2.80 $3.07
2021-10-04 $2.52 $2.79 $3.07
2021-10-05 $2.51 $2.79 $3.06
2021-10-06 $2.51 $2.78 $3.06
2021-10-07 $2.50 $2.78 $3.05
2021-10-08 $2.50 $2.77 $3.05
2021-10-11 $2.49 $2.77 $3.05
2021-10-12 $2.49 $2.76 $3.04
2021-10-13 $2.48 $2.76 $3.04
2021-10-14 $2.48 $2.76 $3.03
2021-10-15 $2.48 $2.75 $3.03
2021-10-18 $2.47 $2.75 $3.02
2021-10-19 $2.47 $2.74 $3.02
2021-10-20 $2.46 $2.74 $3.01
2021-10-21 $2.46 $2.73 $3.01
2021-10-22 $2.45 $2.73 $3.00
2021-10-25 $2.45 $2.72 $3.00
2021-10-26 $2.44 $2.72 $3.00
2021-10-27 $2.44 $2.72 $2.99
2021-10-28 $2.43 $2.71 $2.99
2021-10-29 $2.43 $2.71 $2.98
2021-11-01 $2.43 $2.70 $2.98
2021-11-02 $2.42 $2.70 $2.97

About BioLineRx Ltd.

BioLineRx Ltd BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. Its development pipeline consists of three primary clinical-stage therapeutic candidates, which include BL-8040, a novel peptide for the treatment of multiple cancer and hematological indications; BL-7010, a novel co-polymer for the treatment of celiac disease and glu... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT